Results 131 to 140 of about 109,215 (254)

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option

open access: yesNefrología (English Edition), 2017
Understanding the role of the complement system in the pathogenesis of atypical haemolytic uraemic syndrome and other thrombotic microangiopathies (TMA) has led to the use of anti-complement therapy with eculizumab in these diseases, in addition to its ...
Elena Román   +8 more
doaj   +1 more source

Rescue by Hypothermic Oxygenated Machine Perfusion for Unexpected Long Prolongation of Cold Preservation Time in Expanded Criteria Donor Kidneys Can Achieve Favorable 2‐Year Outcomes

open access: yesClinical Transplantation, Volume 40, Issue 5, May 2026.
ABSTRACT Background Hypothermic oxygenated machine perfusion (HOPE) is occasionally used to overcome logistical issues and allow longer cold preservation time (CPT); however, reports regarding these situations in older brain‐dead donors are lacking.
Silvia Mingozzi   +16 more
wiley   +1 more source

The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies

open access: yesJournal of Thrombosis and Haemostasis, 2016
Essentials Molecular diagnostics has improved the differentiation of acute thrombotic microangiopathys (TMAs). Atypical hemolytic uremic syndrome may have features mimicking thrombotic thrombocytopenic purpura.
Elizabeth Phillips   +11 more
semanticscholar   +1 more source

CD19/BCMA‐Targeted Chimeric Antigen Receptor‐T Cell Therapy for Anti‐HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study

open access: yesHLA, Volume 107, Issue 5, May 2026.
ABSTRACT Antibodies targeting foreign HLA molecules can be detrimental in transplantation. Nonetheless, existing desensitisation methods for anti‐HLA antibodies frequently prove insufficient. We conducted a single‐arm pilot study to evaluate CD19/B cell maturation antigen (BCMA) chimeric antigen receptor T (CAR‐T) cell therapy for desensitising anti ...
Haiqiong Zheng   +15 more
wiley   +1 more source

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series

open access: yes
British Journal of Haematology, Volume 208, Issue 5, Page 1858-1862, May 2026.
Ekaterina Balaian   +6 more
wiley   +1 more source

Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology. [PDF]

open access: yesBMC Nephrol, 2023
Von Tokarski F   +11 more
europepmc   +1 more source

Microangiopathic Anemia without Thrombocytopenia and Kidney Disease in a Child with Diarrhea Caused by Shiga Toxin-Producing Escherichia coli [PDF]

open access: yes, 2017
A child with a history of diarrhea presented with transient anemia, reticolucytosis, and red blood cell fragmentation. Blood pressure and levels of blood platelets, creatinine, and urea were normal, as were results of urinalysis.
Bianchetti, Mario G.   +4 more
core  

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review. [PDF]

open access: yesDiagnostics (Basel), 2023
Mocanu A   +10 more
europepmc   +1 more source

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature

open access: yesAnnals of Hematology
Human immunodeficiency virus (HIV) is a rare cause of thrombotic microangiopathies (TMA), that can present either with normal ADAMTS13 activity (referred as HIV-related TMA) or suppressed ADAMTS13 activity (referred as HIV-related acquired thrombotic ...
Silvio Rao   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy